Physician

Mark A Monsour, MD

According to 2025 Medicare claims, Mark Monsour, MD (NPI: 1326156746) practices urology in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is DAYTON PHYSICIANS, LLC (NPI: 1902844947; TIN: 203130844) and primary practice location at 45459-4780. Monsour is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Monsour's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 495 traditional Medicare patients, billed 13,103 HCPCS/CPT codes, and received $416,778 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 2,007 prescription claims across 441 beneficiaries totaling $2,517,359 in drug costs, led by Erleada (Apalutamide). DME data shows 153 claims. Open Payments data shows 53 records totaling $189,206. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $203,529 to $416,778. Similarly, Part D prescription costs have moved sharply higher in recent years, from $133,687 to $2,517,359. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	621	7,529	$203,529
2016	758	9,239	$276,083
2017	833	12,740	$340,307
2018	939	9,184	$346,130
2019	829	8,415	$326,505
2020	616	9,502	$314,860
2021	595	13,985	$369,747
2022	587	11,946	$328,990
2023	552	10,786	$366,970
2024	495	13,103	$416,778

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	527	2,442	$133,687
2016	594	2,851	$242,081
2017	594	2,879	$375,773
2018	728	3,165	$1,119,199
2019	656	2,758	$1,027,163
2020	543	2,228	$1,738,397
2021	518	1,908	$2,802,488
2022	462	1,646	$3,497,599
2023	419	1,658	$2,752,894
2024	441	2,007	$2,517,359

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	207	$49,957
2016	N/R	202	$58,183
2017	31	280	$70,444
2018	24	242	$68,900
2019	26	252	$74,555
2020	28	267	$83,245
2021	17	190	$62,328
2022	28	193	$73,258
2023	35	163	$83,047
2024	27	153	$76,462

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	123	142	$163
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	108	108	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	222	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	167	303	$12
81003	Automated urinalysis test	292	506	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	62	1,870	$920,756
Orgovyx	Relugolix	277	8,288	$776,957
Xtandi	Enzalutamide	51	1,530	$399,655
Abiraterone Acetate	Abiraterone Acetate	212	6,360	$168,252
Lupron Depot	Leuprolide Acetate	20	2,028	$145,186

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	12	46	$54,964
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	15	55	$20,339
A4332	Lubricant, individual sterile packet, each	N	N/R	27	$726
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	N/R	25	$433

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$1,643	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$187,562	Sumitomo Pharma America, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark A. Monsour, MD?

Tedicare shows public-source Medicare data for Mark A. Monsour, MD (NPI 1326156746), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark A. Monsour, MD have ACO affiliation data?

Mark A. Monsour, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Mark A. Monsour, MD?

Mark A. Monsour, MD is linked to DAYTON PHYSICIANS, LLC (billing NPI 1902844947) in the available physician profile data.

Does Mark A. Monsour, MD have Open Payments data?

Mark A. Monsour, MD has 53 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.